As of press release, according to incomplete statistics, the market includes Follett, Jimi Technology, Dil Laser, Fangyuan, Red Dragonfly, Yuanli Technology, Kexing Pharmaceuticals, Huiyu Pharmaceuticals, Chipper Microelectronics, Yuanchen Technology, Shuangyuan Technology, Fengxing Co., Ltd., Weizhixiang, Jieya Co., Ltd., Mingdian Shares, Yuexin Health, Libertech, Haitian Ruisheng, Guosheng Intelligence, Yunyong Technology, Maipu Medical, China Media Holdings, Tongli Risheng, Xilun Biosheng Twenty-six A-share listed companies, including the Federation, disclosed plans to repurchase or increase their holdings. Specifically, the four listed companies announced plans to increase their holdings. Among them, the controlling shareholder of China Media Holdings plans to increase their holdings by 40 million yuan to 80 million yuan. Twenty-two listed companies disclosed repurchase plan announcements. Among them, Follett plans to repurchase 300 million to 600 million yuan of A-shares, involving the largest amount; Jieya Co., Ltd. plans to buy back 20 million yuan to 40 million yuan of shares, all of which will be cancelled and the company's registered capital reduced accordingly.
近30家上市公司盘后披露回购或增持计划公告 福莱特拟3-6亿元回购
Nearly 30 listed companies announced plans to repurchase or increase their holdings after the market, and Follett plans to repurchase 300 to 600 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.